Core Viewpoint - The A-share market is experiencing a high-level fluctuation, with several foreign financial giants expressing optimism about the future market performance [1][2]. Group 1: Goldman Sachs Insights - Goldman Sachs predicts that the Chinese stock market is entering a slow bull market, expecting major indices to rise by approximately 30% by the end of 2027, driven by a 12% growth in earnings and a 5%-10% upward adjustment in valuations [2][4]. - The firm identifies four key supports for this sustained bull market: favorable policies, accelerated economic growth, low current valuations, and strong capital inflows [4][5]. - Investors are advised to shift their mindset from "selling high" to "buying low" as the bull market unfolds, focusing on growth stocks, particularly in sectors like AI and emerging private enterprises [6]. Group 2: JPMorgan Insights - JPMorgan maintains a positive outlook on the CSI 300 index, anticipating that the shift of household assets towards the stock market will sustain the rebound trend until the end of 2026 [7]. - The firm emphasizes the potential of the "anti-involution" theme and service consumption opportunities, which could lead to an investment boom over the next 18-24 months [7][8]. - JPMorgan also highlights that compared to developed markets, China's service consumption has significant room for growth, particularly in healthcare, financial services, and entertainment sectors [8]. Group 3: UBS Insights - UBS analysts believe the market outlook is positive in the medium term, with growth style likely remaining the main investment theme despite a recent shift towards value stocks [9]. - The firm attributes the recent market style changes to factors such as escalating US-China trade tensions and profit-taking in the tech sector, but expects these factors to have limited impact on medium-term trends [9][10]. - UBS suggests that the current risk-reward profile for investing in growth stocks, particularly in the ChiNext index, remains favorable [10].

Core Viewpoint - The U.S. government shutdown has entered its 22nd day, becoming the second longest in history, with potential implications for economic data and Federal Reserve decision-making [1][2] Economic Data Impact - The shutdown is causing a "data black hole," leading to the suspension of key economic data releases, which poses a direct challenge for the Federal Reserve's decision-making process [2] - Morgan Stanley estimates that 750,000 federal employees will be furloughed daily, which will temporarily inflate the unemployment rate by 44 basis points, despite eventual back pay [2][3] Economic Loss Assessment - Despite the chaos in data, Morgan Stanley believes the actual economic loss is manageable, estimating a GDP drag of about 0.25%, with most impacts expected to be repaired in the following quarter [3] - Federal employees will miss their first full paycheck this Friday, exacerbating economic damage, and the White House warns of potential disruptions in military pay and federal food assistance [3] Political Stalemate - The shutdown stems from a deadlock between Democrats and Republicans over healthcare subsidies, with Democrats demanding relief for 22 million Americans facing rising insurance premiums [4] - Former President Trump has stated that negotiations will not occur until the shutdown ends, complicating the path to a resolution [4] Cost Disagreement - The core disagreement revolves around the cost of extending healthcare subsidies, which were initially introduced as emergency measures during the pandemic and are projected to increase federal debt by $350 billion over the next decade [5] - Moderate senators have not made progress in private negotiations, with key figures expressing skepticism about finding a way out of the deadlock [5]

Core Viewpoint - Goldman Sachs' China equity strategy team predicts a sustained upward trend in the Chinese stock market, with major indices expected to rise approximately 30% by the end of 2027, driven by a 12% growth in earnings and a further valuation adjustment of 5% to 10% [1] Group 1: Factors Supporting the Bull Market - Policy benefits are becoming more favorable [1] - Corporate earnings growth is accelerating, influenced by AI reshaping profit structures, increased capital expenditure from AI, "anti-involution" measures boosting profitability, and the competitiveness of Chinese companies in international markets, leading to an estimated earnings growth rate of around 12% [1] - Chinese companies are currently undervalued, with the index's price-to-earnings ratio at mid-cycle levels, low bond yields, and a historical valuation discount compared to global markets, alongside favorable conditions from the Federal Reserve's policy easing [1] - The capital flow into the Chinese stock market remains strong, with a structural trend of capital inflow beginning, as global investors seek diversification and have a continued underweight in the Chinese market [1] Group 2: Investment Strategy Recommendations - Investors are advised to focus on excess return strategies, particularly in growth stocks, emphasizing leading private enterprises in China, AI-related themes, companies excelling in international markets, "anti-involution" concepts, and small-cap A-shares [2] - A balanced approach is suggested through shareholder return investment portfolios to achieve high cash yield [2]

Core Viewpoint - Goldman Sachs' report indicates that the investment logic in the Chinese stock market is undergoing a fundamental shift, entering a more sustainable and less volatile "slow bull" phase [1] Group 1: Market Outlook - Analysts predict a potential 30% increase in key Chinese stock indices, including A-shares and H-shares, by the end of 2027, driven by earnings growth and valuation recovery [2] - The anticipated rise will be supported by an average annual compound growth rate (CAGR) of approximately 12% in earnings and a 5-10% valuation re-rating, marking a transition from a "hope" phase to a "growth" phase [3][7] Group 2: Supporting Pillars - **Pillar 1: Policy Support** The overall policy environment in China has shifted to a more market-friendly stance, reducing left-tail risks and enhancing shareholder returns through governance reforms [8][9][10] - **Pillar 2: Growth Drivers** Despite a slowdown in macroeconomic growth, three new drivers are expected to push earnings per share (EPS) growth to a "low double-digit" level (around 12%): - AI contributions are projected to add 3 percentage points annually due to increased capital expenditure by tech giants [13] - Anti-involution policies are expected to normalize profit margins, contributing 1.5 percentage points to EPS growth [14] - The trend of Chinese companies seeking global revenue sources is also expected to add 1.5 percentage points to EPS growth [15] - **Pillar 3: Valuation Recovery** Current valuations are deemed reasonable, with the MSCI China Index trading at a 12-month forward P/E ratio of 12.9x, indicating significant upside potential not fully reflected in prices [16][17] - **Pillar 4: Capital Inflows** A significant reallocation of assets from real estate and fixed income to equities is anticipated, with over 6 trillion RMB potentially moving into the stock market in the coming years [18] Group 3: Market Behavior - The report suggests a shift from a "sell on rallies" strategy to a "buy on dips" approach, reflecting a more strategic allocation mindset [5] - Since the low point at the end of 2022, the MSCI China Index has rebounded by 81%, recovering about half of the previous market value loss, although it has experienced four major pullbacks averaging 22% [6]

Core Viewpoint - Goldman Sachs predicts a more sustainable upward trend in the Chinese stock market, with major indices expected to rise by approximately 30% by the end of 2027, driven by a 12% trend in earnings growth and a potential valuation uplift of 5% to 10% [1] Group 1: Supportive Factors for Stock Market Growth - Policy benefits are opening up, with supportive measures introduced a year ago, demand-side stimulus, and the "14th Five-Year Plan" aimed at growth rebalancing and mitigating external risks, while the new "National Nine Articles" enhances shareholder returns [1] - Growth is set to accelerate again, as AI is reshaping the profit landscape, with capital expenditures in AI increasingly boosting earnings, leading to a projected trend in earnings per share growth of around 12% [1] - The Chinese stock market has long been undervalued compared to global markets, with favorable conditions from the Federal Reserve's policy easing and a potential decline in China's real interest rates benefiting stock valuations [1] Group 2: Capital Inflow Trends - A structural trend of capital inflow into the stock market may have already begun, with potential asset reallocation from residents to stocks bringing in trillions of yuan [1] - Externally, the demand for investment diversification and the continued underweighting of the Chinese market by global investors have brought China back into the spotlight for international investment [1]

（原标题：慢牛正在形成！多家外资机构力挺A股，高盛：未来两年有望涨30%） 在香港市场上，恒生指数从10月2日高点累计回调超5%，恒生科技指数累计回调近12%。 但高盛认为，尽管中国股票可能出现回调，但随着牛市的展开，投资者的惯常思维应从"逢高减仓"转变 为"逢低买入"。 与黄金市场的短期谨慎态度形成对比，机构对A股市场的长期信心持续凸显。 据证券时报，高盛发布最新研报称，中国股市将进入更为持久的上涨阶段，预计关键指数到2027年底将 有约30%的上涨空间，主要由12%的盈利趋势增长和5%-10%的进一步重估潜力推动。 慢牛行情正在展开，四大理由支撑 自2022年末的周期低点以来，MSCI中国指数已反弹了80%，但在这期间，一度遭遇了4次重大的下跌。 而近两周来，中国股票似乎又面临一定的回调压力：上证指数在10月9日突破3900点创下新高之后，未 能更进一步，目前仍持续徘徊在3900点整数关附近。沪深300指数则从10月9日的高点累计回调了近 3%。 惠理集团投资组合总监盛今表示：从估值、政策支持、产业升级和外资回流等多方面来看，中国资产中 长期仍具备一定的吸引力。其中，从估值层面来看，A股整体估值水平仍低于 ...

Core Viewpoint - Goldman Sachs predicts that the Chinese stock market will enter a more sustained upward phase, with key indices expected to rise by approximately 30% by the end of 2027, driven primarily by a 12% growth in earnings trends and a further revaluation potential of 5%-10% [1] Group 1 - Chinese stocks are still deeply discounted relative to global markets, with potential asset reallocation in China amounting to several trillion dollars [1] - Current market sentiment is influenced by the US-China rivalry, which suppresses risk appetite, and investors may need to wait for uncertainties to dissipate [1] - Key upcoming events such as the Fourth Plenary Session, the Federal Reserve's interest rate meeting, and the APEC summit are focal points for market participants regarding potential US-China leadership meetings [1] Group 2 - In the medium to long term, the bull market is unlikely to end, and any market corrections may present good opportunities for asset allocation [1]

智通财经APP获悉，高盛最新研报预计，在市场化政策支持、企业盈利增长以及强劲资金流入的推动 下，中国基准股指到2027年末有望实现30%的涨幅。 "我们如今认为，中国股市的上涨趋势将更具持续性，"包括Kinger Lau在内的策略师在周三发布的报告 中写道。当前，中国股市正迎来波动幅度更小的稳步攀升阶段，"这标志着股市周期正从预期驱动转向 增长驱动"。 高盛指出，需求端刺激政策、人工智能发展带动的盈利增长以及境内外资金的持续流入，共同构成了中 国股市的上涨动力。该行预计未来三年中国企业盈利年均增速可达12%，股票估值较当前水平有望提升 5%-10%。 不过策略师也提醒道，四季度宏观经济周期性放缓，以及关税风险再度升温，"可能会成为投资者获利 了结的理由"。但除非这些问题进一步加剧，"我们仍建议保持持仓，并在市场回调时择机加仓"。 上月，高盛策略师曾表示，鉴于当前中国股市估值处于低位，且家庭与机构投资者配置比例存在提升空 间，投资者应对中国股票采取"逢低买入"策略。今年7月，该机构还将MSCI中国指数的12个月目标点位 从85点上调至90点，理由是中美贸易协议的前景有所改善。 MSCI中国指数在10月初曾突破这 ...

Core Insights - The MSCI China Index has rebounded 80% from its cycle low at the end of 2022, despite experiencing four significant pullbacks [1] - The Chinese stock market is expected to enter a more sustainable upward trend, with major indices projected to rise approximately 30% by the end of 2027, driven by a 12% growth in earnings and a further 5%-10% adjustment in valuations [1] Valuation Factors - Current index price-to-earnings (P/E) ratio is at a mid-cycle level, with low bond yields and a historical valuation discount of Chinese stocks compared to global markets [1] - The easing of Federal Reserve policies and the potential decline in China's (real) interest rates are favorable for stock valuations [1] Investment Strategy - The existing macro risks may lead to short-term market corrections, but as the bull market unfolds, investor sentiment should shift from "selling on highs" to "buying on lows" [1]

0:00 高盛发布研报称，中国股市将进入更为持久的上涨阶段，预计关键指数到2027年底将有约30%的上涨空 间，主要由12%的盈利趋势增长和5%-10%的进一步重估潜力推动。分析师Kinger Lau等在报告中指出， 中国股票相对全球股市仍存在深度折价，潜在的中国资产再配置资金规模可达数万亿美元。随着牛市的 展开，宏观风险仍可能引发阶段性回调，但主导心态应从"逢高减仓"转向"逢低买入"。 ...